Walleye Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$262K Sell
2,900
-18,100
-86% -$1.66M ﹤0.01% 3155
2025
Q4
$1.89M Buy
21,000
+2,600
+14% +$247K 0.01% 1925
2025
Q3
$1.81M Buy
18,400
+11,500
+167% +$1.14M 0.01% 1649
2025
Q2
$629K Sell
6,900
-5,500
-44% -$532K ﹤0.01% 2445
2025
Q1
$1.4M Sell
12,400
-14,600
-54% -$1.56M 0.01% 1708
2024
Q4
$2.85M Buy
27,000
+400
+2% +$42.9K 0.01% 1460
2024
Q3
$2.87M Sell
26,600
-1,200
-4% -$131K 0.01% 1618
2024
Q2
$3.02M Sell
27,800
-19,300
-41% -$2.28M 0.01% 1719
2024
Q1
$6.22M Buy
47,100
+31,700
+206% +$3.96M 0.01% 1148
2023
Q4
$1.87M Sell
15,400
-24,900
-62% -$2.78M ﹤0.01% 1840
2023
Q3
$4.52M Buy
40,300
+38,100
+1,732% +$4.84M 0.01% 1101
2023
Q2
$320K Buy
+2,200
New +$299K ﹤0.01% 2739
2022
Q4
Sell
-4,600
Closed -$481K 3697
2022
Q3
$481K Buy
+4,600
New +$505K 0.01% 1502
2019
Q4
Sell
-2,575
Closed -$343K 2327
2019
Q3
$343K Buy
+2,575
New +$333K 0.02% 925
2019
Q2
Sell
-103
Closed -$13K 2116
2019
Q1
$13K Buy
+103
New +$11.7K ﹤0.01% 1388

Other funds holding ZBH

Walleye Capital's ZBH Position: Q1 2026 in Review

Walleye Capital reduced its Zimmer Biomet (ZBH) stake by 33% in Q1 2026, selling an estimated $244K and leaving 5,445 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Walleye Capital first reported a position in ZBH in Q4 2019 and has held it in 13 quarters since. The position peaked at $15.5M in Q3 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Walleye Capital held 5,445 shares of Zimmer Biomet worth $492K as of Q1 2026.
  • Walleye Capital sold 2,657 Zimmer Biomet shares in Q1 2026, an estimated $244K.
  • Zimmer Biomet made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2684 holding.
  • Walleye Capital first reported a position in Zimmer Biomet in Q4 2019 and has held it in 13 quarters since.
  • Walleye Capital's Zimmer Biomet position peaked at $15.5M in Q3 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.